New Study for those who are overweight but don’t have Type 2 Diabetes

About the Study

This study is for individuals with Obesity or Overweight without Type 2 Diabetes. The purpose of the study is to determine if the study medication is safe and effective in reducing body weight. Participants will receive a once-weekly investigational injection of either the study medication or placebo. The study is testing three different doses of the medication: 7.5 mg, 12.5 mg, and 17.5 mg.

Join the study if you meet the following requirements:

• Age 18 years or older
• Does not have Type 2 Diabetes
• BMI greater than 27
• Willing, motivated, and able to complete trial procedures